Kinarus Therapeutics Holding AG
SIX:KNRS

Watchlist Manager
Kinarus Therapeutics Holding AG Logo
Kinarus Therapeutics Holding AG
SIX:KNRS
Watchlist
Price: 15 CHF 416 566.67% Market Closed
Market Cap: 19.5B CHF
Have any thoughts about
Kinarus Therapeutics Holding AG?
Write Note

Net Margin
Kinarus Therapeutics Holding AG

0%
Current
0.1%
Average
2.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-13.9m
/
Revenue
0

Net Margin Across Competitors

Country CH
Market Cap 19.5B CHF
Net Margin N/A
Country US
Market Cap 36.9B USD
Net Margin
8%
Country US
Market Cap 25.7B USD
Net Margin
5%
Country IE
Market Cap 15.4B EUR
Net Margin
14%
Country US
Market Cap 18.3B USD
Net Margin
0%
Country IN
Market Cap 1.6T INR
Net Margin
11%
Country CN
Market Cap 106.5B CNY
Net Margin
0%
Country SG
Market Cap 19.1B SGD
Net Margin
14%
Country UK
Market Cap 10.4B GBP
Net Margin
7%
Country CN
Market Cap 83B CNY
Net Margin
-1%
Country TR
Market Cap 374.7B TRY
Net Margin
29%

Profitability Report

View the profitability report to see the full profitability analysis for Kinarus Therapeutics Holding AG.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
0%
=
Net Income
-13.9m
/
Revenue
0
What is the Net Margin of Kinarus Therapeutics Holding AG?

Based on Kinarus Therapeutics Holding AG's most recent financial statements, the company has Net Margin of 0%.